Literature DB >> 4384514

Some characteristics of hepatic microsomal systems which metabolize aminopyrine in the rat and rabbit.

T E Gram, J T Wilson, J R Fouts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4384514

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  10 in total

1.  Toxicity of lead acetate to female rabbits after chronic subcutaneous administration. 1. Biochemical and clinical effects.

Authors:  H E Falke; W C Zwennis
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

2.  NMR-derived models of amidopyrine and its metabolites in complexes with rabbit cytochrome P450 2B4 reveal a structural mechanism of sequential N-dealkylation.

Authors:  Arthur G Roberts; Sara E A Sjögren; Nadezda Fomina; Kathy T Vu; Adah Almutairi; James R Halpert
Journal:  Biochemistry       Date:  2011-03-04       Impact factor: 3.162

3.  Experimental hepatobiliary injury. Comparison of in vivo drug elimination with in vitro drug-metabolizing enzyme capacity in the rat.

Authors:  R A Willson; F E Hart; J T Hew
Journal:  Dig Dis Sci       Date:  1981-01       Impact factor: 3.199

4.  Inhibition of aminopyrine demethylation and binding to cytochrome P-450 by its main metabolites in rat liver microsomes [proceedings].

Authors:  A Bast; J Noordhoek
Journal:  Br J Pharmacol       Date:  1980-01       Impact factor: 8.739

5.  Pyran and polyribonucleotides: differences in biological activities.

Authors:  P S Morahan; W Regelson; A E Munson
Journal:  Antimicrob Agents Chemother       Date:  1972-07       Impact factor: 5.191

6.  Dose dependence of the 14C-aminopyrine breath test. Intrasubject comparison of tracer and pharmacological doses.

Authors:  I Gikalov; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

7.  The effect of oxine-5-sulphonic acid on the hepatic drug metabolism in the rat.

Authors:  L Manzo; R Passoni; A D Segre; F Berte; A Crema
Journal:  Experientia       Date:  1976-10-15

8.  Output of 14CO2 in breath after oral administration of (14C-methyl) aminopyrine in hepatitis, cirrhosis and hepatic bilharziasis: its relationship to aminopyrine pharmacokinetics.

Authors:  J Noordhoek; J Dees; E M Savenije-Chapel; J H Wilson
Journal:  Eur J Clin Pharmacol       Date:  1978-05-31       Impact factor: 2.953

9.  Antiviral activity and side effects of polyriboinosinic-cytidylic acid complexes as affected by molecular size.

Authors:  P S Morahan; A E Munson; W Regelson; S L Commerford; L D Hamilton
Journal:  Proc Natl Acad Sci U S A       Date:  1972-04       Impact factor: 11.205

10.  Validated HPLC determination of 4-dimethylaminoantipyrine in different suppository bases.

Authors:  E Kalmár; B Kormányos; G Szakonyi; G Dombi
Journal:  Indian J Pharm Sci       Date:  2014-01       Impact factor: 0.975
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.